Atypical CD11c+T-bet+ B cell expansion marks distinct immune signature in Autoimmune Hepatitis and AIH/PBC overlap
Background
Autoimmune hepatitis (AIH) and primary biliary cholangitis (PBC) are distinct autoimmune liver diseases (AILDs) with differing pathogeneses and treatment responses. A subset of patients presents with features of both, termed AIH/PBC overlap syndrome. While traditionally considered T cell-driven, B cells are increasingly recognized as crucial contributors to AILD progression. This study specifically investigates CD11c+T-bet+ B cells, a subset implicated in other autoimmune conditions but previously unexplored in AILDs, to identify unique disease signatures.
Study Design
Researchers isolated circulating peripheral blood mononuclear cells (PBMC) from N=15 patients with Autoimmune Hepatitis, N=8 with Primary Biliary Cholangitis, N=11 with AIH/PBC overlap syndrome, and N=12 healthy donors. B and T cell subsets were meticulously analyzed using conventional and spectral flow cytometry. Clinical and laboratory parameters were recorded, and serum levels of IL-21, sCD40L, and BAFF were quantified via ELISA and flow cytometry to assess cytokine profiles.
Results
Total CD19+ B-cell frequencies remained comparable across all patient groups and healthy donors. However, a significant expansion of the canonical atypical B-cell subset, defined as CD11c+T-bet+CD21-, was observed in both Autoimmune Hepatitis and AIH/PBC overlap patients, a finding absent in Primary Biliary Cholangitis patients. Phenotypic characterization revealed these expanded cells were enriched in double-negative and naïve-like B-cell subsets. They also displayed the expected chemokine receptor profile of atypical B cells, with higher CXCR3 and lower CXCR5 expression compared to conventional B cells.
Circulating follicular helper T cells (
cTfh) were notably increased in Autoimmune Hepatitis and AIH/PBC overlap patients, showing a strong correlation with the overallT-bet+ B-cellcompartment. Furthermore, serumIL-21levels were elevated in patients with AILDs, particularly pronounced in those identified as treatment non-responders.
Key Findings
CD11c+T-bet+CD21- B cellswere significantly expanded in Autoimmune Hepatitis and AIH/PBC overlap patients.- This atypical B-cell expansion was not observed in Primary Biliary Cholangitis patients.
- Expanded atypical B cells showed higher
CXCR3and lowerCXCR5expression. - Circulating follicular helper T cells (
cTfh) were increased in AIH and AIH/PBC, correlating withT-bet+ B cells. - Serum
IL-21levels were higher in AILD patients, especially in treatment non-responders.
Why It Matters
This research provides critical insights into the distinct immunological landscapes of Autoimmune Hepatitis and AIH/PBC overlap compared to Primary Biliary Cholangitis. Identifying the expansion of atypical CD11c+T-bet+ B cells and increased cTfh frequencies as specific hallmarks for AIH and AIH/PBC overlap opens new avenues for targeted therapeutic strategies. Instead of broad immunosuppression, future treatments could focus on modulating these specific B-cell subsets or their associated pathways, such as IL-21 signaling. This could lead to more precise, disease-specific interventions, potentially improving outcomes for patients who currently face challenges with standard-of-care therapies or exhibit overlap syndromes. The findings suggest a shift towards biomarker-driven treatment selection.
autoimmune hepatitis
primary biliary cholangitis
aih/pbc overlap
b cells
t cells
flow cytometry